戻る
「早戻しボタン」を押すと検索画面に戻ります。

今後説明を表示しない

[OK]

コーパス検索結果 (1語後でソート)

通し番号をクリックするとPubMedの該当ページを表示します
1 n activated Na(+)-K(+)-2Cl(-) cotransporter (NKCC2).
2 s (WNKs)] as well as its substrates (NCC and NKCC2).
3  the apical Na(+)/K(+)/2Cl(-) co-transporter NKCC2.
4  chloride affinity and transport activity of NKCC2.
5 ot sufficient for anterograde trafficking of NKCC2.
6 domain of OS9 had no effect on its action on NKCC2.
7 osmotic stimulatory effect was observed with NKCC2.
8 ted protein (MAL)/VIP17 in the regulation of NKCC2.
9 ated chimeras of the mouse NKCC1 and the rat NKCC2.
10 ded by an additional exon in NKCC1 absent in NKCC2.
11  sodium-potassium-chloride co-transporter 2, NKCC2.
12 ion-chloride cotransporters KCC3, NKCC1, and NKCC2.
13 gulatory threonines in the amino terminus of NKCC2.
14 olved in calcineurin-dependent modulation of NKCC2.
15 to mutations in the Na-K-2Cl co-transporter, NKCC2.
16 e key components in the phosphoregulation of NKCC2.
17 ) as a novel and specific binding partner of NKCC2.
18 ciation involves mainly the immature form of NKCC2.
19 in partners specifically involved in ERAD of NKCC2.
20  is known about phosphatases that deactivate NKCC2.
21  protein degradation of the immature form of NKCC2.
22 phorylation as well as expression of NCC and NKCC2.
23 munoprecipitation of SPAK with WNK1, NCC and NKCC2.
24 ignaling via PKA and other kinases activates NKCC2.
25  toward the Na(+)-K(+)-2Cl(-) cotransporter, NKCC2.
26  the apical Na(+)/K(+)/2Cl(-) co-transporter NKCC2.
27 ase A (PKA), increasing steady-state surface NKCC2.
28 ocytosis and promotes VAMP2 interaction with NKCC2.
29 ical translocation and surface expression of NKCC2.
30 e is known about partners that interact with NKCC2.
31 QP2 (121+/-4 versus 100+/-1%; P<0.001), ISOM NKCC2 (133+/-1 versus 100+/-4%; P<0.05), and cortex plus
32 nd cortex plus outer stripe of outer medulla NKCC2 (142+/-16 versus 100+/-9%; P<0.05).
33     Mutations in the Na-K-2Cl cotransporter (NKCC2), a mediator of renal salt reabsorption, cause Bar
34 pite a lack of SPAK and OSR1, phosphorylated NKCC2 abundance was still high, suggesting the existence
35  there was no Bartter phenotype with reduced NKCC2 activity and increased NCC expression in Romk1(-/-
36 ted NOS3 and Akt by Western blotting, and 4) NKCC2 activity by fluorescence microscopy.
37 ion of NKCC2 at S126 might help to stabilize NKCC2 activity in the absence of AC6.
38 hese results support a model in which apical NKCC2 activity is matched to basolateral Cl exit through
39                                              NKCC2 activity is modulated by N-terminal phosphorylatio
40                       Endothelin-1 inhibited NKCC2 activity, an effect that was blocked by dominant-n
41                                              NKCC2 and AnxA2 interact in a phosphorylation-dependent
42                We have previously shown that NKCC2 and its disease-causing mutants are subject to reg
43 ve modulation of ERAD components specific to NKCC2 and its disease-causing mutants might provide nove
44                                   By mapping NKCC2 and KCC2 antibody staining on these dendrites, we
45 ing on these dendrites, we further show that NKCC2 and KCC2 are preferentially located in the proxima
46  depolarization and hyperpolarization at the NKCC2 and KCC2 compartments, respectively, and underlies
47  We show here that selective blockade of the NKCC2 and KCC2 cotransporters located on starburst dendr
48                      We demonstrated that 1) NKCC2 and MAL/VIP17 colocalize and coimmunoprecipitate i
49        We conclude that VAMP3 interacts with NKCC2 and mediates its constitutive exocytic delivery to
50 nction of the sodium chloride cotransporters NKCC2 and NCC (key components of salt reabsorption in th
51 nactive state, WNK3 is a potent inhibitor of NKCC2 and NCC activity.
52 R1-independent phosphorylation sites on both NKCC2 and NCC and changes in sodium transport along the
53  phosphorylate the ion cotransporters NKCC1, NKCC2 and NCC, leading to the identification of several
54 se-active WNK3 is a potent activator of both NKCC2 and NCC-mediated transport.
55 ot in OSR1 to the same degree, and activated NKCC2 and NCC.
56 ly, immunocytochemistry analysis showed that NKCC2 and OS9 co-localize at the endoplasmic reticulum.
57 lipid raft-associated trafficking factor for NKCC2 and provides mechanistic insight into the regulati
58                      Phosphorylation of S126 NKCC2 and T58 NCC, induced by the V2 receptor agonist (1
59 )]vasopressin increases steady-state surface NKCC2 and that the protein kinase A (PKA) inhibitor H-89
60  screening identified an interaction between NKCC2 and the cytosolic protein, annexin A2 (AnxA2).
61         Measurements of steady-state surface NKCC2 and the rate of NKCC2 endocytosis in freshly isola
62 e kinases, regulate the furosemide-sensitive NKCC2 and the thiazide-sensitive NCC, kidney-specific CC
63 f +/+, yet no differences were found between NKCC2 +/+ and +/- mice in BP, blood gas, electrolytes, c
64 tion of the Na(+)/K(+)/2Cl(-) cotransporter (NKCC2) and AQP2, with less phosphorylation of AQP2 at se
65 on of ion transporters in the loop of Henle (NKCC2) and distal nephron (NCC, ENaC, and pendrin) as we
66 tion in three genes-SLC12A3 (NCCT), SLC12A1 (NKCC2) and KCNJ1 (ROMK)-causing rare recessive diseases
67 nsporters Na(+) -K(+) -2Cl(-) cotransporter (NKCC2) and Na(+) -Cl(-) cotransporter (NCC) via phosphor
68 e renal Na(+) -K(+) -2Cl(-) cotransporter 2 (NKCC2) and Na(+) Cl(-) cotransporter (NCC).
69 sporter (NKCC2) at serine residue 126 (pS126 NKCC2) and of the Na-Cl cotransporter (NCC) at threonine
70 tion of the Na(+)-K(+)-2Cl(-)-cotransporter (NKCC2) and the Na(+)-Cl(-)-cotransporter (NCC) by vasopr
71 ium, two chloride co-transporters, NKCC1 and NKCC2, and also affect other related ion co-transporters
72 echanism associated with mutations depriving NKCC2, and also all other members of the SLC12A family,
73 composed of the levels of mRNA for vimentin, NKCC2, and E-cadherin and of 18S ribosomal RNA provided
74 m-transporting proteins, including NaPi-IIa, NKCC2, and ENaC, did not change, although the abundance
75 ary expression of the Na-K-2Cl-cotransporter NKCC2, and greater furosemide-sensitive Na+ reabsorption
76 ome to the renal Na-K-2Cl cotransporter gene NKCC2, and identify frameshift or non-conservative misse
77 e regulatory threonine residues among NKCC1, NKCC2, and NCC family members, together with the fact th
78               Cross linking studies of NHE3, NKCC2, and NCC revealed that high molecular weight compl
79 +)-dependent chloride cotransporters (NKCC1, NKCC2, and NCC) are activated by phosphorylation to play
80 PAK/OSR1 to bind to and phosphorylate NKCC1, NKCC2, and NCC.
81             MMDD1 cells express COX-2, bNOS, NKCC2, and ROMK, but not Tamm-Horsfall protein, and show
82 acids are highly conserved between NKCC1 and NKCC2, and similarities are also present in the Na-Cl co
83  we examine the kinetic properties of NKCC1, NKCC2, and the endogenous HEK-293 cell cotransporter.
84 fferences among the three splice variants of NKCC2, and they support a model in which a reentrant loo
85 um-dependent sodium-chloride co-transporter, NKCC2, and thiazide-sensitive sodium-chloride cotranspor
86 n in mice augmented the abundance of phospho-NKCC2, and treatment of isolated TAL with cyclosporine i
87 companied by a significant decrease in THP-, NKCC2- and AQP1-positive loop of Henle nephron segments
88 bumetanide-sensitive Na-K-2Cl cotransporter [NKCC2]), and the distal convoluted tubule (the thiazide-
89 due to loss-of-function mutations in NCC and NKCC2 are consistent, in part, with their functional rol
90 quired for ER exit and surface expression of NKCC2 are evolutionarily conserved in all members of the
91 the existence of three different isoforms of NKCC2 are unclear.
92 variants of the renal Na-K-Cl cotransporter (NKCC2) are found in distinct regions of the thick ascend
93 ransporter (NCC) and Na-K-2Cl cotransporter (NKCC2) are involved in Gitelman and Bartter syndrome, re
94                          Here, we identified NKCC2 as a target of the calcineurin Abeta isoform.
95 asopressin also increased phosphorylation of NKCC2 at both Ser126 (more than fivefold) and Ser874 (mo
96 Increased AC6-independent phosphorylation of NKCC2 at S126 might help to stabilize NKCC2 activity in
97 la, there was significant phosphorylation of NKCC2 at SPAK/OSR1-dependent sites despite a complete ab
98                           Phosphorylation of NKCC2 at SPAK/OSR1-dependent sites was lower than in SPA
99 P17 also is involved in the stabilization of NKCC2 at the apical membrane in vivo.
100  exocytic delivery, decreasing the amount of NKCC2 at the TAL apical surface.
101 osphorylation of the Na-K-2Cl cotransporter (NKCC2) at serine residue 126 (pS126 NKCC2) and of the Na
102 er874 of the Na(+):K(+):2Cl(-) cotransporter NKCC2, at Ser552 of the Na(+):H(+) exchanger NHE3, and a
103 es a selective loss of NCC function, whereas NKCC2 becomes hyperphosphorylated.
104 porin 2, or Na(+)-K(+)-2Cl(-) co-transporter NKCC2/BSC1 protein abundances or UT-A1 mRNA abundance in
105 ice isoforms of the Na-K-2Cl co-transporter (NKCC2/BSC1) are expressed along the thick ascending limb
106 R1) with the cotransporters KCC3, NKCC1, and NKCC2 but not KCC1 and KCC4.
107 38 +/- 8% and increased steady-state surface NKCC2 by 37 +/- 8%, without changing total NKCC2 express
108 d surface expression and raft association of NKCC2 by 5-fold upon low chloride hypotonic stimulation,
109 6 +/- 11% and increased steady-state surface NKCC2 by 67 +/- 27% (p < 0.05).
110 IP17 increases the cell surface retention of NKCC2 by attenuating its internalization, and 4) this co
111                              cAMP stimulates NKCC2 by enhancing steady-state apical membrane levels o
112  cAMP stimulates steady-state apical surface NKCC2 by stimulating exocytic insertion and that this pr
113 isms underlying the short term activation of NKCC2 by vasopressin in vivo, finding that administratio
114 brary through a yeast two-hybrid assay using NKCC2 C terminus as bait.
115 ney medullae, 2) a 150-amino acid stretch of NKCC2 C-terminal tail is involved in the interaction wit
116 tions in the apical Na-K-2Cl co-transporter, NKCC2, cause type I Bartter syndrome, a life-threatening
117                          Here we report that NKCC2 co-immunoprecipitates with VAMP2 in rat TALs, and
118 cells, and stimulation of PKA enhanced VAMP2-NKCC2 co-immunoprecipitation in TALs.
119 SPAK activity and phosphorylation of NCC and NKCC2 co-transporters at the residues phosphorylated by
120 nd stimulating the Na-Cl (NCC) and Na-K-2Cl (NKCC2) co-transporters, which regulate salt reabsorption
121 s analysis revealed an amino acid stretch in NKCC2 containing apical sorting information.
122 We reported that constitutive endocytosis of NKCC2 controls NaCl absorption in native THALs; however,
123 among several analyzed motifs present in the NKCC2 COOH terminus, only those required for ER exit and
124  in the activation and surface expression of NKCC2 could play an important role in the regulated abso
125 imb (mTAL) apical Na+-K+-2Cl- cotransporter (NKCC2) decreased by 52 % (P < 0.02) and 44 % (P < 0.01),
126       VAMP2 was not involved in constitutive NKCC2 delivery.
127                                        Thus, NKCC2-dependent brain mechanisms that regulate osmotic s
128  a mechanism that may include alterations in NKCC2-dependent sodium reabsorption.
129 e kidney-specific NaK2Cl cotransporter, BSC1/NKCC2, do not survive.
130               Halving the mRNA expression of NKCC2 does not affect BP or fluid balance because of com
131 of a 4-gene signature of mRNAs for vimentin, NKCC2, E-cadherin, and 18S rRNA diagnostic of interstiti
132                             Knockdown of HNS NKCC2 elicited profound effects on fluid balance followi
133 er: the absorptive isoform BSC1 (also called NKCC2, encoded by Slc12a1 in mouse) that is exclusively
134 dynamin-2, clathrin, and lipid rafts mediate NKCC2 endocytosis and maintain steady-state apical surfa
135 ive THALs; however, the pathways involved in NKCC2 endocytosis are unknown.
136                         We hypothesized that NKCC2 endocytosis at the apical surface depends on dynam
137 egative Dyn2K44A in THALs slowed the rate of NKCC2 endocytosis by 38 +/- 8% and increased steady-stat
138            Disruption of lipid rafts blunted NKCC2 endocytosis by 39 +/- 4% and silencing caveolin-1
139 m interacting with synaptojanin also blunted NKCC2 endocytosis by 52 +/- 5%.
140 ated endocytosis with chlorpromazine blunted NKCC2 endocytosis by 54 +/- 6%, while preventing clathri
141 f endogenous dynamin-2 with dynasore blunted NKCC2 endocytosis by 56 +/- 11% and increased steady-sta
142 f steady-state surface NKCC2 and the rate of NKCC2 endocytosis in freshly isolated rat THALs showed t
143 identifying the endocytic pathway for apical NKCC2 endocytosis.
144 t VAMP3 selectively mediates cAMP-stimulated NKCC2 exocytic delivery and surface expression in TALs.
145                              cAMP stimulates NKCC2 exocytic delivery via protein kinase A (PKA), incr
146  silencing VAMP3 in vivo blocks constitutive NKCC2 exocytic delivery, decreasing the amount of NKCC2
147    VAMP3 is not required for cAMP-stimulated NKCC2 exocytic delivery.
148 ssion and completely blocked cAMP-stimulated NKCC2 exocytic delivery.
149 ed cumulative apical membrane exocytosis and NKCC2 exocytic insertion in TALs.
150                                          The NKCC2 expressed in these mice was highly glycosylated an
151 se gene coding for the NaK2Cl cotransporter (NKCC2) expressed in kidney epithelial cells of the thick
152    Consequently, mice lacking AC6 have lower NKCC2 expression and a mild Bartter syndrome-like phenot
153 blunted cAMP-stimulated steady-state surface NKCC2 expression and completely blocked cAMP-stimulated
154                   Renal AC6 determines total NKCC2 expression and mediates vasopressin-induced NKCC2/
155 wn of OS9 by small interfering RNA increased NKCC2 expression by increasing the co-transporter stabil
156   Additionally, VAMP3 is required for normal NKCC2 expression, renal function, and blood pressure.
157 e NKCC2 by 37 +/- 8%, without changing total NKCC2 expression.
158 ate p62 displayed the strongest reduction of NKCC2 expression.
159 teristics we expressed cDNAs encoding rabbit NKCC2 F, A, and B in Xenopus oocytes and determined the
160 variants of the renal Na-K-Cl cotransporter (NKCC2 F, A, and B) are spatially distributed along the t
161 oduces a premature stop in codon W625 of the NKCC2 gene (SCL12A1).
162 apical sorting of the protein encoded by the NKCC2 gene.
163       Serine-threonine kinases that activate NKCC2 have been identified, but less is known about phos
164           Confocal imaging of apical surface NKCC2 in isolated perfused TALs confirmed a stimulatory
165 stal nephron did not alter the expression of NKCC2 in mTAL and decreased AQP2 protein only in OM but
166 sis and maintain steady-state apical surface NKCC2 in native THALs.
167 pression of total and phosphorylated NCC and NKCC2 in respective nephron segments.
168  rapidly normalized the abundance of phospho-NKCC2 in SORLA-deficient mice, and a functional interact
169 lso found constitutive exocytic insertion of NKCC2 in TALs over time, which was increased by 3-fold i
170  NCC and the Na(+)-K(+)-2Cl(-) cotransporter NKCC2 in the distal convoluted tubule and the thick asce
171                              Thus absence of NKCC2 in the mouse causes polyuria that is not compensat
172 on of vasopressin restored the expression of NKCC2 in the outer medulla as well as the expression and
173  VAMP3 in mice decreased total expression of NKCC2 in the TAL and lowered blood pressure.
174  There is no functional linking of ROMK1 and NKCC2 in the TAL.
175 n and no clear change in the distribution of NKCC2 in the thick ascending limb (TAL) cells.
176 he medullary Na(+)-K(+)-2Cl(-) cotransporter NKCC2 in these mice compared with wild-type mice, an eff
177 , KS-WNK1 is a negative regulator of NCC and NKCC2 in vivo and plays an important role in the control
178  glucose or NaCl, upregulated renal AQP2 and NKCC2 in vivo in BB rats.
179 plasmalemmal translocation and activation of NKCC2 in vivo.
180 glycosylation and cell surface expression of NKCC2, independently of the expression system.
181  mice that are deficient in the B isoform of NKCC2 indicates a limited role for NKCC2B for overall sa
182                          Here we report that NKCC2 interacts with the vesicle fusion protein VAMP3, a
183 raft-mediated endocytosis completely blocked NKCC2 internalization.
184                           Although a pool of NKCC2 is present in cytoplasmic vesicles, the distributi
185                                        Since NKCC2 is the molecular target of the loop diuretics bume
186 e-sensitive Na(+)-K(+)-2Cl(-)-cotransporter (NKCC2) is crucial for NaCl reabsorption in kidney thick
187 e-sensitive Na(+)-K(+)-2Cl(-) cotransporter (NKCC2) is responsible for urine concentration and helps
188             The renal Na-K-Cl cotransporter (NKCC2) is selectively expressed in the apical membranes
189 he renal-specific Na+-K+-2Cl- cotransporter (NKCC2) is the major salt transport pathway of the apical
190 AnxA2 effect involved only nonphosphorylated NKCC2, it appears to affect NKCC2 trafficking.
191                                NKCC2 mRNA of NKCC2 +/- kidney was 55 +/- 6% of +/+, yet no difference
192  the renal specific Na-K-2Cl co-transporter (NKCC2) lead to type I Bartter syndrome, a life-threateni
193                         Steady-state surface NKCC2 levels in the apical membrane are maintained by a
194 n of both high- and low-affinity isoforms of NKCC2 may permit transport and Cl-dependent tubuloglomer
195                       Na-K-Cl cotransporter (NKCC2)-mediated sodium chloride reabsorption in the thic
196 ing of NKCC2 to the apical surface regulates NKCC2-mediated NaCl absorption and blood pressure.
197 se models suggest that OSR1 mainly activates NKCC2-mediated sodium transport along the thick ascendin
198 apical renal Na(+)-K(+)-2Cl(-) cotransporter NKCC2 mediates NaCl absorption by the thick ascending li
199                                              NKCC2 +/- mice had a near-normal level of NKCC2 protein
200 oscope images demonstrates a 55% increase in NKCC2 molecules at the apical membrane, suggesting the a
201                                              NKCC2 mRNA of NKCC2 +/- kidney was 55 +/- 6% of +/+, yet
202                                          The NKCC2 mutant animals should be valuable for uncovering n
203                                              NKCC2 mutations can be excluded in some Bartter's kindre
204 ntial phenotypes in heterozygous carriers of NKCC2 mutations.
205                    In contrast, mutations of NKCC2 N-glycosylation sites abolished the effects of OS9
206 he abundance of total and cell-surface NHE3, NKCC2, NCC, alpha-ENaC and cleaved gamma-ENaC compared t
207  expression and mediates vasopressin-induced NKCC2/NCC phosphorylation.
208 transporters neither conferred activation to NKCC2 nor prevented activation of NKCC1.
209 that naturally occurring mutations depriving NKCC2 of its distal COOH-terminal tail and interfering w
210 strate that the differential distribution of NKCC2 on the proximal dendrites and KCC2 on the distal d
211 me residues with corresponding residues from NKCC2 or the Na-Cl cotransporter resulted in cation affi
212 bumetanide-sensitive Na-K-2Cl cotransporter (NKCC2) or the ATP-regulated potassium channel ROMK (KCNJ
213 ected with H(2)O or with RNA encoding SGLT1, NKCC2, or PepT1.
214 eptor with A-type repeats (SORLA) may affect NKCC2 phosphoregulation, we used SORLA-knockout mice to
215 a in the apical region of TAL cells and less NKCC2 phosphorylation and activity compared with litterm
216 increases and kinase-inactive WNK3 decreases NKCC2 phosphorylation at Thr-184 and Thr-189, sites requ
217                               Thus, enhanced NKCC2 phosphorylation in the SPAK knock-out may be expla
218 in) causes a 2-fold increase in mouse kidney NKCC2 phosphorylation, as detected with a phosphospecifi
219                               With regard to NKCC2 phosphorylation, the stimulatory effect of 1-desam
220 aporin 2 (AQP2) and Na-K-2Cl co-transporter (NKCC2), pivotal factors in urinary concentration, in AVP
221 ositive with NKCC1 primers and negative with NKCC2 primers.
222      AC6 is also a stimulator of total renal NKCC2 protein abundance in medullary and cortical thick
223    NKCC2 +/- mice had a near-normal level of NKCC2 protein and no clear change in the distribution of
224  In cells overexpressing OS9, total cellular NKCC2 protein levels were markedly decreased, an effect
225  by a reduction in the expression of NCC and NKCC2 protein without changes in mRNA levels.
226 athway in renal cells that degrades immature NKCC2 proteins.
227                                   Homozygous NKCC2-/- pups were born in expected numbers and appeared
228            The molecular mechanisms by which NKCC2 reaches the apical surface and their role in renal
229  levels of the apical Na/K/2Cl cotransporter NKCC2 regulate NaCl reabsorption by epithelial cells of
230 to investigate the effect of WNK3 on NCC and NKCC2, related kidney-specific transporters that mediate
231                                              NKCC2 rose in the ISOM but was not reversed with insulin
232                 The three splice variants of NKCC2 showed dramatic differences in their kinetic behav
233 sodium-potassium -chloride co-transporter 2 (NKCC2), sodium chloride co-transporter (NCC), aquaporin
234 odium/potassium/chloride transporter type 2 (NKCC2), sodium/chloride transporter, and Na(+),K(+)-ATPa
235          Thus, the kinetic properties of the NKCC2 splice variants are consistent with the spatial di
236                              To test whether NKCC2 splice variants differ in ion transport characteri
237 egulation of the expression of renal AQP and NKCC2, studies were performed with hyperosmolality that
238 e genes encoding the Na-K-2Cl cotransporter (NKCC2), the potassium channel ROMK, the chloride channel
239                     Na,K,2Cl co-transporter (NKCC2), the primary NaCl uptake pathway in the thick asc
240 organize microdomains, is codistributed with NKCC2 to promote its apical translocation in response to
241                               Trafficking of NKCC2 to the apical surface regulates NKCC2-mediated NaC
242  the mechanisms underlying the regulation of NKCC2 trafficking in renal cells are scarcely known.
243 onphosphorylated NKCC2, it appears to affect NKCC2 trafficking.
244  associated with a 60% decrease in medullary NKCC2 transporter expression determined by Western blot.
245  ammoniagenesis but reduced abundance of the NKCC2 transporter responsible for medullary accumulation
246 tation of the kinetic characteristics of the NKCC2 variants to the luminal concentrations of substrat
247 sence of the terminally glycosylated form of NKCC2 was not due to reduced synthesis or increased rate
248                The Na-K-2Cl cotransporter 2 (NKCC2) was thought to be kidney specific.
249 ing mechanism by which cAMP increases apical NKCC2, we measured cumulative apical membrane exocytosis
250  variants to interact with and phosphorylate NKCC2, whereas only full-length SPAK promoted the activa
251 (500 microm) stimulated steady-state surface NKCC2, whereas the Epac-selective agonist 8-p-chlorophen
252 een identified in the mammalian kidney: BSC1/NKCC2 which localizes to the apical thick ascending limb
253 tory epithelia and non-epithelial cells; and NKCC2, which is present exclusively in the kidney, in th
254 umulation in secretory epithelial cells, and NKCC2, which mediates apical Na+K+Cl entry into renal ep
255 se models suggest that OSR1 mainly activates NKCC2, while SPAK mainly activates NCC, with possible cr
256                               Association of NKCC2 with lipid rafts facilitates its AVP-induced apica
257 mbrane domain 2 endows different versions of NKCC2 with unique kinetic behaviors.

WebLSDに未収録の専門用語(用法)は "新規対訳" から投稿できます。
 
Page Top